A new molecular mechanism of neuronal nicotinic acetylcholine receptor blockade
✍ Scribed by N. N. Churaev; É. P. Zatsepin; O. I. Dobrotina
- Publisher
- Springer US
- Year
- 1991
- Tongue
- English
- Weight
- 302 KB
- Volume
- 111
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Neuronal nicotinic acetylcholine receptor (nAChR) agonists have been demonstrated to exhibit antinociceptive, antihyperalgesic, and antiallodynic effects across a range of preclinical models of pain. Yet, to date, no drugs have been successfully developed and approved for the treatment
## Abstract The potential antiparkinsonian effects of the centrally acting, subtype‐selective neuronal nicotinic acetylcholine receptor agonist (S)‐(7‐)‐‐5‐ethynyl‐3‐(1‐methyl‐2‐pyrrolidinyl)‐pyridine (SIB‐1508Y) was assessed on motor symptoms and disability scale ratings in three monkeys previousl
## Abstract magnified image A group of novel 4,5‐dihydro‐3‐methylisoxazolyl derivatives, structurally related to epiboxidine (=(1__R__,4__S__,6__S__)‐6‐(3‐methylisoxazol‐5‐yl)‐7‐azabicyclo[2.2.1]heptane), was prepared __via__ 1,3‐dipolar cycloaddition of acetonitrile oxide to different olefins. Ta
## Abstract A group of agonists for the α7 neuronal nicotinic acetylcholine receptors (nAChRs) was investigated, and their free energies of binding Δ__G__~bind~ were calculated by applying the molecular mechanics Poisson–Boltzmann surface area (MM‐PBSA) approach. This method, based on molecular dyn